|
|
||||||||
Biology of Reproduction, Vol 14, 175-185, Copyright © 1976 by Society for the Study of Reproduction
1 Department of Zoology, University of Tennessee,
Knoxville, Tennessee 37916 and
Reproduction Research Laboratories,
Department of Biochemistry,
University of Georgia,
Athens, Georgia 30602 The ultrastructure of the zonae pellucidae of hamster ova after treatment with zona
precipitating antibody (ZPA) was investigated. The hamster zona as viewed by transmission and
scanning electron microscopy reveals an intricate network of interconnecting fibers. This network
of interstitial zona fibers results in the formation of a porous outer zona region adjacent to a more
compact but porous inner zina. The canaliculi bounded by these fibers provide viaducts by which
processes of follicular cells may pass through the zona and interact with the vitelline surface. ZPA treatment of zonae results in the interaction of the specific immunoglobulins with the
fibrous network of the outer region but does not occlude the interstitial pores. The pattern of
ZPA-zona interaction greatly accentuates the substructure of the outer zona and resembles a layer
or aggregations of fine to medium-course granules and/or electron dense particles which can be
observed as a dense precipitate with the light microscope. Treatment of zonae with control media,
preimmunization serum or ZPA absorbed with ovary, does not produce a zona precipitate. These
zonae when viewed with the electron microscope lack the distinct, dense precipitate observed in
ZPA-treated zonae. In view of the pattern of ZPA interaction with the fibrous components of the
zona and the lack of pore occlusion, ZPA may in fact block or mask sperm receptors and/or
enzyme substrate(s) during sperm penetration or mechanically inhibit zona dissolution during
implantation.
Note:
ACKNOWLEDGMENTS
The pregnant mare's serum gonadotropin
(NIAMDD-PMSG-1) used in these studies was generously supplied by Dr. A. F. Parlow of the National
Institute of Arthritis and Metabolic Diseases Rat
Pituitary Hormone Program.
The investigation was supported by NIH grants
HD-06226 to Dr. J. C. Daniel, Jr., and HD-04020 to
Dr. C. A. Shivers, and by NIH Contract 69-2103 and
by Ford Foundation Grant 680-0805A to Dr. W. L.
Williams.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |